The Safety and Immunogenicity of Haemophilus Influenzae Type b Vaccine in Different Injection Site
Phase 4 Study of Haemophilus Influenzae Type b Vaccine in Different Injection Site
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Beijing, China
- Beijing Chaoyang Women's and Children's Hospital
-
Beijing, China
- Beijing Dongba Hospital
-
Beijing, China
- Cuigezhuang community health service centers
-
Beijing, China
- Xiaohongmen community health service centers
-
-
Beijing
-
Beijing, Beijing, China
- Beijing Huaxin Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- participants were under 1 years old, and were in good healthy
- participants were full-time pregnancy and birth weight were more than 2.5 kg
Exclusion Criteria:
- current infectious fever or acute disease
- a history of hypersensitivity to study vaccine components especially tetanus toxoid
- a history of allergy, autoimmune, convulsions, seizures heredity disease
- a history of Hib vaccination or Hib disease
- a history of congenital deformity, developmental disorders or serious chronic diseases, muscle injection contradiction, and immunosuppressive agents, hormone or immunoglobulin received.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Inoculation in upper arm deltoid
Inoculation of Hib vaccine of two brands in upper arm deltoid
|
Inoculation of Hib vaccine of two brands in upper arm deltoid
Inoculation of Hib vaccine of two brands in vastus lateralis muscle
|
|
Experimental: Inoculation in vastus lateralis muscle
Inoculation of Hib vaccine of two brands in vastus lateralis muscle
|
Inoculation of Hib vaccine of two brands in upper arm deltoid
Inoculation of Hib vaccine of two brands in vastus lateralis muscle
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence rate of adverse events of Haemophilus influenzae type b vaccine in different injection site
Time Frame: one year
|
one year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Antibody titre of Haemophilus influenzae type b vaccine in different injection site
Time Frame: one year
|
one year
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: nianmin shi, Beijing chaoyang district center for disease control and prevention
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- BJCDPC-4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.